nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—PTGER3—Prostanoid ligand receptors—PTGER4—ankylosing spondylitis	0.0642	0.138	CbGpPWpGaD
Bimatoprost—PTGFR—Prostanoid ligand receptors—PTGER4—ankylosing spondylitis	0.048	0.103	CbGpPWpGaD
Bimatoprost—PTGER1—Prostanoid ligand receptors—PTGER4—ankylosing spondylitis	0.047	0.101	CbGpPWpGaD
Bimatoprost—PTGER3—Eicosanoid ligand-binding receptors—PTGER4—ankylosing spondylitis	0.0427	0.0916	CbGpPWpGaD
Bimatoprost—PTGER3—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.0353	0.0758	CbGpPWpGaD
Bimatoprost—PTGFR—Eicosanoid ligand-binding receptors—PTGER4—ankylosing spondylitis	0.0319	0.0685	CbGpPWpGaD
Bimatoprost—PTGER1—Eicosanoid ligand-binding receptors—PTGER4—ankylosing spondylitis	0.0312	0.067	CbGpPWpGaD
Bimatoprost—PTGFR—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.0264	0.0567	CbGpPWpGaD
Bimatoprost—PTGER1—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.0259	0.0555	CbGpPWpGaD
Bimatoprost—PTGER3—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.0245	0.0526	CbGpPWpGaD
Bimatoprost—Dinoprostone—PTGER4—ankylosing spondylitis	0.0221	1	CrCbGaD
Bimatoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.0183	0.0393	CbGpPWpGaD
Bimatoprost—PTGER1—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.0179	0.0385	CbGpPWpGaD
Bimatoprost—Corneal oedema—Dexamethasone—ankylosing spondylitis	0.0136	0.0265	CcSEcCtD
Bimatoprost—Corneal oedema—Betamethasone—ankylosing spondylitis	0.0136	0.0265	CcSEcCtD
Bimatoprost—Corneal erosion—Betamethasone—ankylosing spondylitis	0.0136	0.0265	CcSEcCtD
Bimatoprost—Corneal erosion—Dexamethasone—ankylosing spondylitis	0.0136	0.0265	CcSEcCtD
Bimatoprost—Vitreous floaters—Betamethasone—ankylosing spondylitis	0.0125	0.0244	CcSEcCtD
Bimatoprost—Vitreous floaters—Dexamethasone—ankylosing spondylitis	0.0125	0.0244	CcSEcCtD
Bimatoprost—Sensation of foreign body—Prednisolone—ankylosing spondylitis	0.0104	0.0204	CcSEcCtD
Bimatoprost—Conjunctival oedema—Betamethasone—ankylosing spondylitis	0.0102	0.02	CcSEcCtD
Bimatoprost—Conjunctival oedema—Dexamethasone—ankylosing spondylitis	0.0102	0.02	CcSEcCtD
Bimatoprost—Conjunctival haemorrhage—Betamethasone—ankylosing spondylitis	0.00872	0.017	CcSEcCtD
Bimatoprost—Conjunctival haemorrhage—Dexamethasone—ankylosing spondylitis	0.00872	0.017	CcSEcCtD
Bimatoprost—Sensation of foreign body—Dexamethasone—ankylosing spondylitis	0.00872	0.017	CcSEcCtD
Bimatoprost—Sensation of foreign body—Betamethasone—ankylosing spondylitis	0.00872	0.017	CcSEcCtD
Bimatoprost—Hypertrichosis—Triamcinolone—ankylosing spondylitis	0.00823	0.0161	CcSEcCtD
Bimatoprost—Hypertrichosis—Methylprednisolone—ankylosing spondylitis	0.00822	0.0161	CcSEcCtD
Bimatoprost—Conjunctival hyperaemia—Prednisolone—ankylosing spondylitis	0.00774	0.0151	CcSEcCtD
Bimatoprost—Hypertrichosis—Betamethasone—ankylosing spondylitis	0.00747	0.0146	CcSEcCtD
Bimatoprost—Hypertrichosis—Dexamethasone—ankylosing spondylitis	0.00747	0.0146	CcSEcCtD
Bimatoprost—Chronic obstructive pulmonary disease—Methotrexate—ankylosing spondylitis	0.00723	0.0141	CcSEcCtD
Bimatoprost—Hypertrichosis—Prednisone—ankylosing spondylitis	0.00651	0.0127	CcSEcCtD
Bimatoprost—Conjunctival hyperaemia—Betamethasone—ankylosing spondylitis	0.00646	0.0126	CcSEcCtD
Bimatoprost—Conjunctival hyperaemia—Dexamethasone—ankylosing spondylitis	0.00646	0.0126	CcSEcCtD
Bimatoprost—Hirsutism—Prednisolone—ankylosing spondylitis	0.00586	0.0114	CcSEcCtD
Bimatoprost—Hirsutism—Triamcinolone—ankylosing spondylitis	0.00539	0.0105	CcSEcCtD
Bimatoprost—Hirsutism—Methylprednisolone—ankylosing spondylitis	0.00537	0.0105	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Triamcinolone—ankylosing spondylitis	0.00526	0.0103	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Methylprednisolone—ankylosing spondylitis	0.00525	0.0103	CcSEcCtD
Bimatoprost—Keratitis—Prednisolone—ankylosing spondylitis	0.00525	0.0103	CcSEcCtD
Bimatoprost—Hirsutism—Betamethasone—ankylosing spondylitis	0.00489	0.00955	CcSEcCtD
Bimatoprost—Hirsutism—Dexamethasone—ankylosing spondylitis	0.00489	0.00955	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Dexamethasone—ankylosing spondylitis	0.00478	0.00933	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Betamethasone—ankylosing spondylitis	0.00478	0.00933	CcSEcCtD
Bimatoprost—Blepharitis—Dexamethasone—ankylosing spondylitis	0.00462	0.00902	CcSEcCtD
Bimatoprost—Blepharitis—Betamethasone—ankylosing spondylitis	0.00462	0.00902	CcSEcCtD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00438	0.0094	CbGpPWpGaD
Bimatoprost—Keratitis—Betamethasone—ankylosing spondylitis	0.00438	0.00856	CcSEcCtD
Bimatoprost—Keratitis—Dexamethasone—ankylosing spondylitis	0.00438	0.00856	CcSEcCtD
Bimatoprost—Hirsutism—Prednisone—ankylosing spondylitis	0.00426	0.00832	CcSEcCtD
Bimatoprost—Stinging—Prednisolone—ankylosing spondylitis	0.0042	0.00821	CcSEcCtD
Bimatoprost—Eye irritation—Prednisolone—ankylosing spondylitis	0.00399	0.00779	CcSEcCtD
Bimatoprost—Stinging—Triamcinolone—ankylosing spondylitis	0.00386	0.00755	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00376	0.00806	CbGpPWpGaD
Bimatoprost—Stinging—Betamethasone—ankylosing spondylitis	0.00351	0.00685	CcSEcCtD
Bimatoprost—Stinging—Dexamethasone—ankylosing spondylitis	0.00351	0.00685	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Methotrexate—ankylosing spondylitis	0.00348	0.00679	CcSEcCtD
Bimatoprost—Cough increased—Triamcinolone—ankylosing spondylitis	0.00342	0.00668	CcSEcCtD
Bimatoprost—Cataract—Triamcinolone—ankylosing spondylitis	0.00329	0.00643	CcSEcCtD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00328	0.00703	CbGpPWpGaD
Bimatoprost—Inflammation—Methylprednisolone—ankylosing spondylitis	0.00322	0.00629	CcSEcCtD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00321	0.00688	CbGpPWpGaD
Bimatoprost—Cataract—Dexamethasone—ankylosing spondylitis	0.00298	0.00583	CcSEcCtD
Bimatoprost—Cataract—Betamethasone—ankylosing spondylitis	0.00298	0.00583	CcSEcCtD
Bimatoprost—Burning sensation—Methotrexate—ankylosing spondylitis	0.00298	0.00581	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00286	0.00614	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00281	0.00603	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00275	0.0059	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.0027	0.00579	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.00264	0.00567	CbGpPWpGaD
Bimatoprost—Dry eye—Betamethasone—ankylosing spondylitis	0.00262	0.00513	CcSEcCtD
Bimatoprost—Dry eye—Dexamethasone—ankylosing spondylitis	0.00262	0.00513	CcSEcCtD
Bimatoprost—Hypercholesterolaemia—Prednisone—ankylosing spondylitis	0.00262	0.00511	CcSEcCtD
Bimatoprost—Visual disturbance—Prednisolone—ankylosing spondylitis	0.00261	0.00509	CcSEcCtD
Bimatoprost—Cataract—Prednisone—ankylosing spondylitis	0.0026	0.00508	CcSEcCtD
Bimatoprost—Skin discolouration—Methotrexate—ankylosing spondylitis	0.00229	0.00447	CcSEcCtD
Bimatoprost—Eye pain—Dexamethasone—ankylosing spondylitis	0.00228	0.00446	CcSEcCtD
Bimatoprost—Eye pain—Betamethasone—ankylosing spondylitis	0.00228	0.00446	CcSEcCtD
Bimatoprost—Dry skin—Prednisolone—ankylosing spondylitis	0.00226	0.00443	CcSEcCtD
Bimatoprost—Visual disturbance—Betamethasone—ankylosing spondylitis	0.00218	0.00425	CcSEcCtD
Bimatoprost—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.00218	0.00425	CcSEcCtD
Bimatoprost—AKR1C3—Disease—ANTXR2—ankylosing spondylitis	0.00216	0.00464	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00214	0.00459	CbGpPWpGaD
Bimatoprost—Inflammation—Methotrexate—ankylosing spondylitis	0.00213	0.00416	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00209	0.00449	CbGpPWpGaD
Bimatoprost—Cystitis noninfective—Methotrexate—ankylosing spondylitis	0.00202	0.00395	CcSEcCtD
Bimatoprost—Cystitis—Methotrexate—ankylosing spondylitis	0.002	0.0039	CcSEcCtD
Bimatoprost—Asthma—Triamcinolone—ankylosing spondylitis	0.00196	0.00384	CcSEcCtD
Bimatoprost—Dry skin—Dexamethasone—ankylosing spondylitis	0.00189	0.00369	CcSEcCtD
Bimatoprost—Dry skin—Betamethasone—ankylosing spondylitis	0.00189	0.00369	CcSEcCtD
Bimatoprost—Bronchitis—Triamcinolone—ankylosing spondylitis	0.00189	0.00369	CcSEcCtD
Bimatoprost—Bladder pain—Methotrexate—ankylosing spondylitis	0.00187	0.00365	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.00183	0.00357	CcSEcCtD
Bimatoprost—Visual impairment—Prednisolone—ankylosing spondylitis	0.00165	0.00322	CcSEcCtD
Bimatoprost—Dry skin—Prednisone—ankylosing spondylitis	0.00165	0.00322	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00162	0.00347	CbGpPWpGaD
Bimatoprost—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00158	0.00309	CcSEcCtD
Bimatoprost—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00158	0.00308	CcSEcCtD
Bimatoprost—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00157	0.00307	CcSEcCtD
Bimatoprost—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00156	0.00305	CcSEcCtD
Bimatoprost—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00154	0.00301	CcSEcCtD
Bimatoprost—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00151	0.00295	CcSEcCtD
Bimatoprost—Erythema—Prednisolone—ankylosing spondylitis	0.00149	0.00291	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00147	0.00315	CbGpPWpGaD
Bimatoprost—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00147	0.00286	CcSEcCtD
Bimatoprost—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00142	0.00278	CcSEcCtD
Bimatoprost—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00141	0.00276	CcSEcCtD
Bimatoprost—Vision blurred—Prednisolone—ankylosing spondylitis	0.0014	0.00274	CcSEcCtD
Bimatoprost—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00139	0.00271	CcSEcCtD
Bimatoprost—Depression—Prednisone—ankylosing spondylitis	0.00138	0.0027	CcSEcCtD
Bimatoprost—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00137	0.00269	CcSEcCtD
Bimatoprost—Visual impairment—Betamethasone—ankylosing spondylitis	0.00137	0.00269	CcSEcCtD
Bimatoprost—Erythema—Triamcinolone—ankylosing spondylitis	0.00137	0.00267	CcSEcCtD
Bimatoprost—Erythema—Methylprednisolone—ankylosing spondylitis	0.00137	0.00267	CcSEcCtD
Bimatoprost—Vertigo—Prednisolone—ankylosing spondylitis	0.00134	0.00261	CcSEcCtD
Bimatoprost—Eye disorder—Betamethasone—ankylosing spondylitis	0.00133	0.0026	CcSEcCtD
Bimatoprost—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00133	0.0026	CcSEcCtD
Bimatoprost—Asthma—Methotrexate—ankylosing spondylitis	0.0013	0.00253	CcSEcCtD
Bimatoprost—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00129	0.00253	CcSEcCtD
Bimatoprost—Angiopathy—Betamethasone—ankylosing spondylitis	0.00129	0.00253	CcSEcCtD
Bimatoprost—Hypertension—Prednisolone—ankylosing spondylitis	0.00128	0.00251	CcSEcCtD
Bimatoprost—AKR1C3—Disease—B3GNT2—ankylosing spondylitis	0.00127	0.00273	CbGpPWpGaD
Bimatoprost—Erythema—Betamethasone—ankylosing spondylitis	0.00124	0.00243	CcSEcCtD
Bimatoprost—Erythema—Dexamethasone—ankylosing spondylitis	0.00124	0.00243	CcSEcCtD
Bimatoprost—Vertigo—Triamcinolone—ankylosing spondylitis	0.00123	0.0024	CcSEcCtD
Bimatoprost—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00123	0.0024	CcSEcCtD
Bimatoprost—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00122	0.00239	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00121	0.00259	CbGpPWpGaD
Bimatoprost—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00121	0.00236	CcSEcCtD
Bimatoprost—Cough—Triamcinolone—ankylosing spondylitis	0.00119	0.00233	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00118	0.00254	CbGpPWpGaD
Bimatoprost—Hypertension—Triamcinolone—ankylosing spondylitis	0.00118	0.00231	CcSEcCtD
Bimatoprost—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00118	0.0023	CcSEcCtD
Bimatoprost—Eye disorder—Prednisone—ankylosing spondylitis	0.00116	0.00227	CcSEcCtD
Bimatoprost—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00116	0.00226	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00115	0.00226	CcSEcCtD
Bimatoprost—Depression—Methotrexate—ankylosing spondylitis	0.00115	0.00225	CcSEcCtD
Bimatoprost—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00114	0.00223	CcSEcCtD
Bimatoprost—Angiopathy—Prednisone—ankylosing spondylitis	0.00113	0.0022	CcSEcCtD
Bimatoprost—Vertigo—Betamethasone—ankylosing spondylitis	0.00112	0.00218	CcSEcCtD
Bimatoprost—Vertigo—Dexamethasone—ankylosing spondylitis	0.00112	0.00218	CcSEcCtD
Bimatoprost—Infection—Triamcinolone—ankylosing spondylitis	0.00111	0.00217	CcSEcCtD
Bimatoprost—Infection—Methylprednisolone—ankylosing spondylitis	0.00111	0.00216	CcSEcCtD
Bimatoprost—Insomnia—Prednisolone—ankylosing spondylitis	0.0011	0.00215	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.0011	0.00235	CbGpPWpGaD
Bimatoprost—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00109	0.00214	CcSEcCtD
Bimatoprost—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00108	0.00211	CcSEcCtD
Bimatoprost—Erythema—Prednisone—ankylosing spondylitis	0.00108	0.00211	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00107	0.0023	CbGpPWpGaD
Bimatoprost—Hypertension—Dexamethasone—ankylosing spondylitis	0.00107	0.00209	CcSEcCtD
Bimatoprost—Hypertension—Betamethasone—ankylosing spondylitis	0.00107	0.00209	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—B3GNT2—ankylosing spondylitis	0.00107	0.00229	CbGpPWpGaD
Bimatoprost—Anxiety—Betamethasone—ankylosing spondylitis	0.00105	0.00206	CcSEcCtD
Bimatoprost—Anxiety—Dexamethasone—ankylosing spondylitis	0.00105	0.00206	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00105	0.00224	CbGpPWpGaD
Bimatoprost—Pain—Prednisolone—ankylosing spondylitis	0.00104	0.00203	CcSEcCtD
Bimatoprost—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00103	0.00201	CcSEcCtD
Bimatoprost—Vision blurred—Prednisone—ankylosing spondylitis	0.00102	0.00199	CcSEcCtD
Bimatoprost—Insomnia—Triamcinolone—ankylosing spondylitis	0.00101	0.00197	CcSEcCtD
Bimatoprost—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00101	0.00197	CcSEcCtD
Bimatoprost—Infection—Dexamethasone—ankylosing spondylitis	0.00101	0.00197	CcSEcCtD
Bimatoprost—Infection—Betamethasone—ankylosing spondylitis	0.00101	0.00197	CcSEcCtD
Bimatoprost—Visual impairment—Methotrexate—ankylosing spondylitis	0.001	0.00195	CcSEcCtD
Bimatoprost—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000996	0.00195	CcSEcCtD
Bimatoprost—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000994	0.00194	CcSEcCtD
Bimatoprost—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000994	0.00194	CcSEcCtD
Bimatoprost—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000983	0.00192	CcSEcCtD
Bimatoprost—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000981	0.00192	CcSEcCtD
Bimatoprost—Vertigo—Prednisone—ankylosing spondylitis	0.000972	0.0019	CcSEcCtD
Bimatoprost—Eye disorder—Methotrexate—ankylosing spondylitis	0.00097	0.0019	CcSEcCtD
Bimatoprost—Pain—Triamcinolone—ankylosing spondylitis	0.000955	0.00187	CcSEcCtD
Bimatoprost—Angiopathy—Methotrexate—ankylosing spondylitis	0.000942	0.00184	CcSEcCtD
Bimatoprost—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000936	0.00183	CcSEcCtD
Bimatoprost—Hypertension—Prednisone—ankylosing spondylitis	0.000934	0.00182	CcSEcCtD
Bimatoprost—Anxiety—Prednisone—ankylosing spondylitis	0.000917	0.00179	CcSEcCtD
Bimatoprost—Insomnia—Dexamethasone—ankylosing spondylitis	0.000917	0.00179	CcSEcCtD
Bimatoprost—Insomnia—Betamethasone—ankylosing spondylitis	0.000917	0.00179	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000914	0.00179	CcSEcCtD
Bimatoprost—Erythema—Methotrexate—ankylosing spondylitis	0.000904	0.00177	CcSEcCtD
Bimatoprost—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000892	0.00174	CcSEcCtD
Bimatoprost—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000892	0.00174	CcSEcCtD
Bimatoprost—Infection—Prednisone—ankylosing spondylitis	0.000877	0.00171	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000875	0.00171	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000875	0.00171	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000867	0.00186	CbGpPWpGaD
Bimatoprost—Pain—Dexamethasone—ankylosing spondylitis	0.000867	0.00169	CcSEcCtD
Bimatoprost—Pain—Betamethasone—ankylosing spondylitis	0.000867	0.00169	CcSEcCtD
Bimatoprost—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000865	0.00169	CcSEcCtD
Bimatoprost—Skin disorder—Prednisone—ankylosing spondylitis	0.000857	0.00167	CcSEcCtD
Bimatoprost—Vision blurred—Methotrexate—ankylosing spondylitis	0.000852	0.00166	CcSEcCtD
Bimatoprost—Vertigo—Methotrexate—ankylosing spondylitis	0.000812	0.00159	CcSEcCtD
Bimatoprost—Dizziness—Prednisolone—ankylosing spondylitis	0.000803	0.00157	CcSEcCtD
Bimatoprost—Asthenia—Triamcinolone—ankylosing spondylitis	0.000801	0.00157	CcSEcCtD
Bimatoprost—Asthenia—Methylprednisolone—ankylosing spondylitis	0.0008	0.00156	CcSEcCtD
Bimatoprost—Insomnia—Prednisone—ankylosing spondylitis	0.000798	0.00156	CcSEcCtD
Bimatoprost—Pruritus—Triamcinolone—ankylosing spondylitis	0.00079	0.00154	CcSEcCtD
Bimatoprost—Cough—Methotrexate—ankylosing spondylitis	0.000789	0.00154	CcSEcCtD
Bimatoprost—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000788	0.00154	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000782	0.00168	CbGpPWpGaD
Bimatoprost—Dyspepsia—Prednisone—ankylosing spondylitis	0.000777	0.00152	CcSEcCtD
Bimatoprost—Chest pain—Methotrexate—ankylosing spondylitis	0.000769	0.0015	CcSEcCtD
Bimatoprost—Rash—Prednisolone—ankylosing spondylitis	0.000766	0.0015	CcSEcCtD
Bimatoprost—Dermatitis—Prednisolone—ankylosing spondylitis	0.000765	0.00149	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000765	0.00164	CbGpPWpGaD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000764	0.00149	CcSEcCtD
Bimatoprost—Headache—Prednisolone—ankylosing spondylitis	0.000761	0.00149	CcSEcCtD
Bimatoprost—Dizziness—Triamcinolone—ankylosing spondylitis	0.000739	0.00144	CcSEcCtD
Bimatoprost—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000737	0.00144	CcSEcCtD
Bimatoprost—Infection—Methotrexate—ankylosing spondylitis	0.000733	0.00143	CcSEcCtD
Bimatoprost—Asthenia—Betamethasone—ankylosing spondylitis	0.000727	0.00142	CcSEcCtD
Bimatoprost—Asthenia—Dexamethasone—ankylosing spondylitis	0.000727	0.00142	CcSEcCtD
Bimatoprost—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000723	0.00141	CcSEcCtD
Bimatoprost—Nausea—Prednisolone—ankylosing spondylitis	0.000721	0.00141	CcSEcCtD
Bimatoprost—Pruritus—Dexamethasone—ankylosing spondylitis	0.000717	0.0014	CcSEcCtD
Bimatoprost—Pruritus—Betamethasone—ankylosing spondylitis	0.000717	0.0014	CcSEcCtD
Bimatoprost—Skin disorder—Methotrexate—ankylosing spondylitis	0.000716	0.0014	CcSEcCtD
Bimatoprost—Rash—Triamcinolone—ankylosing spondylitis	0.000704	0.00138	CcSEcCtD
Bimatoprost—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000704	0.00137	CcSEcCtD
Bimatoprost—Rash—Methylprednisolone—ankylosing spondylitis	0.000703	0.00137	CcSEcCtD
Bimatoprost—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000702	0.00137	CcSEcCtD
Bimatoprost—Headache—Triamcinolone—ankylosing spondylitis	0.0007	0.00137	CcSEcCtD
Bimatoprost—Headache—Methylprednisolone—ankylosing spondylitis	0.000698	0.00136	CcSEcCtD
Bimatoprost—Dizziness—Betamethasone—ankylosing spondylitis	0.00067	0.00131	CcSEcCtD
Bimatoprost—Dizziness—Dexamethasone—ankylosing spondylitis	0.00067	0.00131	CcSEcCtD
Bimatoprost—Insomnia—Methotrexate—ankylosing spondylitis	0.000667	0.0013	CcSEcCtD
Bimatoprost—Nausea—Triamcinolone—ankylosing spondylitis	0.000663	0.0013	CcSEcCtD
Bimatoprost—Nausea—Methylprednisolone—ankylosing spondylitis	0.000662	0.00129	CcSEcCtD
Bimatoprost—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000658	0.00128	CcSEcCtD
Bimatoprost—Somnolence—Methotrexate—ankylosing spondylitis	0.000656	0.00128	CcSEcCtD
Bimatoprost—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000649	0.00127	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000648	0.00139	CbGpPWpGaD
Bimatoprost—Rash—Betamethasone—ankylosing spondylitis	0.000639	0.00125	CcSEcCtD
Bimatoprost—Rash—Dexamethasone—ankylosing spondylitis	0.000639	0.00125	CcSEcCtD
Bimatoprost—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000638	0.00125	CcSEcCtD
Bimatoprost—Dermatitis—Betamethasone—ankylosing spondylitis	0.000638	0.00125	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000637	0.00124	CcSEcCtD
Bimatoprost—Headache—Betamethasone—ankylosing spondylitis	0.000635	0.00124	CcSEcCtD
Bimatoprost—Headache—Dexamethasone—ankylosing spondylitis	0.000635	0.00124	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000635	0.00136	CbGpPWpGaD
Bimatoprost—Asthenia—Prednisone—ankylosing spondylitis	0.000633	0.00124	CcSEcCtD
Bimatoprost—Pain—Methotrexate—ankylosing spondylitis	0.000631	0.00123	CcSEcCtD
Bimatoprost—Pruritus—Prednisone—ankylosing spondylitis	0.000624	0.00122	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—MMP3—ankylosing spondylitis	0.000617	0.00132	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000612	0.00131	CbGpPWpGaD
Bimatoprost—Nausea—Betamethasone—ankylosing spondylitis	0.000602	0.00118	CcSEcCtD
Bimatoprost—Nausea—Dexamethasone—ankylosing spondylitis	0.000602	0.00118	CcSEcCtD
Bimatoprost—Dizziness—Prednisone—ankylosing spondylitis	0.000584	0.00114	CcSEcCtD
Bimatoprost—Rash—Prednisone—ankylosing spondylitis	0.000556	0.00109	CcSEcCtD
Bimatoprost—Dermatitis—Prednisone—ankylosing spondylitis	0.000556	0.00109	CcSEcCtD
Bimatoprost—Headache—Prednisone—ankylosing spondylitis	0.000553	0.00108	CcSEcCtD
Bimatoprost—Asthenia—Methotrexate—ankylosing spondylitis	0.000529	0.00103	CcSEcCtD
Bimatoprost—Nausea—Prednisone—ankylosing spondylitis	0.000524	0.00102	CcSEcCtD
Bimatoprost—Pruritus—Methotrexate—ankylosing spondylitis	0.000522	0.00102	CcSEcCtD
Bimatoprost—AKR1C3—Disease—HLA-A—ankylosing spondylitis	0.000516	0.00111	CbGpPWpGaD
Bimatoprost—Dizziness—Methotrexate—ankylosing spondylitis	0.000488	0.000953	CcSEcCtD
Bimatoprost—Rash—Methotrexate—ankylosing spondylitis	0.000465	0.000909	CcSEcCtD
Bimatoprost—Dermatitis—Methotrexate—ankylosing spondylitis	0.000465	0.000908	CcSEcCtD
Bimatoprost—Headache—Methotrexate—ankylosing spondylitis	0.000462	0.000903	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—MMP3—ankylosing spondylitis	0.000462	0.00099	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP3—ankylosing spondylitis	0.000452	0.000969	CbGpPWpGaD
Bimatoprost—Nausea—Methotrexate—ankylosing spondylitis	0.000438	0.000856	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—MMP3—ankylosing spondylitis	0.000436	0.000935	CbGpPWpGaD
